| Autumn 2024 | ||
| DATE | SPEAKER(S) | TALK TITLE |
| Sep 4th | James Jahng, Phd Instructor, Cardiovascular Institute, Stanford University | "Repurposing FDA approved drugs for ameliorating myocardial lipotoxicity" |
| Sep 18th | Marielle Koeberlin, Phd Basic Life Research Scientist, Baxter Labs, Stanford University | "A fast-acting lipid cell-cycle checkpoint in G1 prevents mitotic cell death in health and disease" |
| Oct 2nd | Shuke Xiao, Phd Postdoctoral Scholar, Long Lab, Stanford University | "A hiberation-inducible metabolite activates hepatic glucose production" |
| Oct 16th | Alan Tung PhD Student, Long Lab, Stanford University | "MCT6 is required for Lac-Phe efflux and metformin-associated weight loss" |
| Oct 30th | Samuel Lancaster, PhD Scientific Director, Metabolic Health Center, Genetics, Stanford University | "An Encyclopedia of the Cord Blood Metabolome Reveals Maternal-Fetal Interactions and Disease Risk" |
| Nov 13th | Olivia Tsai, PhD Senior Research Scientist, Department of Pediatrics, Stanford University | "Unique lipid signatures derived from phospholipids and sphingolipids may predict the emergence of pancreatitis with asparaginase exposure" |
| Dec 11th | Malene Lindholm, PhD Senior Research Engineer, Department of Medicine, Stanford University | "Charting the molecular terrain of exercise – towards the goal of precision exercise health" |